Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2024ACS OmegaOpen Access

New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMa’Lik D. WoodlandATAnthony ThompsonALAmanda Lipford

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Woodland et al. (2024) studied this question.

synapsesocial.com/papers/68e780c8b6db6435876f3c67https://doi.org/10.1021/acsomega.3c09335
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Developing Safer Anticoagulant Candidates: Structure-Activity Relationship Studies of 5-Amino-Triazole-Based FXIIa Inhibitors2026
  2. 2Discovery of the First Highly Potent, Selective, Irreversible Small-Molecule Factor XIIa Inhibitor for Treating Sepsis2026 · 1 citations
  3. 3Factor XII in Thrombosis and Thromboinflammation: From Molecular Biology to Clinical Translation2026 · 1 citations
  4. 4Sulfonated non‐saccharide molecules and human factor XIa: Enzyme inhibition and computational studies2022 · 11 citations
  5. 5Discovery of Highly Selective, Potent, Covalent, and Orally Bioavailable Factor XIIa Inhibitors for the Treatment of Thrombo-Inflammation2024 · 10 citations